Funding translational work in cell-based therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21726828.
- Also identified by DOI 10.1016/j.stem.2011.06.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The cell therapy branch of the regenerative medicine field has been innovative in developing new models of delivery and development and identifying alternative sources of funding. We discuss the implications of these changes for pharmaceutical companies and the opportunities they offer to a new entrepreneur.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Translational Research, Biomedical